Information Library
Results for: Faster product development - High-quality studies - Central Laboratories
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Quintiles Addresses Key Considerations for Successful Biosimilar Development
Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.
-
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
White Paper — June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Quintiles Names Rick Sax New Head of Integrated Clinical Services
Press Release — May 23, 2011 – Quintiles announced the appointment of Frederic “Rick” Sax as Senior Vice President and Global Head of its Integrated Clinical Services division.rograms.
-
Clinical – Smarter Trials, Accelerated Outcomes
Brochure — February 16, 2011
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
QUINTILES CENTRAL LABORATORY IN JAPAN RECEIVES CAP ACCREDITATION
Press Release — September 7, 2010 - Quintiles' new lab in Tokyo, Japan has received accreditation from the College of American Pathologists (CAP), joining the largest network of fully harmonized, CAP-accredited central labs in the world.
-
Validated Biomarker Menu
Brochure — July 14, 2009
A comprehensive menu of validated cell, fluid and tissue based biomarker assays. -
India Rising: Quintiles Central Laboratory
Video — June 8, 2009
We take look at the rising role of India and Quintiles' ability to offer central laboratory services that continue to meet you needs for clean, reliable and comparable data for your regulatory submissions. -
QUINTILES ADVANCES CANCER TREATMENT THROUGH NEW GENETIC TESTS
Press Release — May 26, 2009 – Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announces the availability of two new laboratory tests used to develop more effective cancer treatments.
Page 1 of 1 (8 results)
